| MLR | mean length response; middle latency response; mixed lymphocyte reaction |
|---|---|
| MLT | left mentotransverse [fetal position] [Lat. mento-laeva transversa]; mean latency time; median letha... |
| MSLT | multiple sleep latency test |
| PML | peripheral motor latency; polymorphonuclear leukocyte; posterior mitral leaflet; progressive multifo... |
| SL | sarcolemma; sclerosing leukoencephalopathy; secondary leukemia; segment length; sensation level; sen... |
| latency |
The time between exposure and the first appearance of an effect.
Ãâó: www.dhs.ca.gov/ohb/HESIS/utsgloss.htm
|
|---|---|
| latency |
The state of apparent inactivity during which time the herpes virus genetic material lies sleeping in a cell without producing virus-specific biochemical changes or evidence of reproduction or illness; latent virus is not detectable by the usual biochemical tests.
Ãâó: biology.kenyon.edu/stures/compsstancik/Glossary.ht...
|
| latency phase |
Psychological term for describing the years before puberty.
Ãâó: www.bddiabetes.co.uk/dyn_en/glossary.html
|
| latency |
The amount of time in nanoseconds (often measured in clock cycles) between a request to read the memory, and when it is actually output. SDRAMs are typically referred to as CL2 or CL3, with CL2 parts being faster.
Ãâó: www.crucial.com/library/glossary.asp
|
| latency period |
The period between exposure to a disease-causing agent and the onset or appearance of disease symptoms. The latency period for asbestos-related diseases ranges from 15 years for asbestosis to 30 years or more for lung cancer and mesothelioma.
Ãâó: www.mesothelioma-legal-resource.com/mesothelioma-m...
|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|